Effects of four antiepileptic drugs on sleep and waking in the rat under both light and dark phases

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 3, 1996, Pages 559-565

  Bertorelli, Rosalia ^a   Ferri, Nives ^a   Adami, Marina ^a   Ongini, Ennio ^a  

^a Research Laboratories   (Italy)

Author keywords

Anticonvulsant drugs; Carbamazepine; Felbamate; Lamotrigine; Phenobarbital; Rat; Sleep wake cycle

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FELBAMATE; LAMOTRIGINE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DARKNESS; DRUG MECHANISM; ELECTROENCEPHALOGRAM; LIGHT; MALE; NONHUMAN; NONREM SLEEP; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REM SLEEP; SEDATION; SLEEP WAKING CYCLE;

EID: 0029866327     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02050-0     Document Type: Article

References (40)

1. Armstrong-James, M.; Fox, K. Evidence for a specific role for cortical NMDA receptors in slow-wave sleep. Brain Res. 451:189-196; 1988.
2. Betts, T.; Goodwin, R.; Withers, R. M.; Yuen, W. C. Human safety of lamotrigine. Epilepsia. 32(Suppl 2.):S17-S21; 1991.
3. Brodie, M. J. Lamotrigine. Lancet 339:1397-1400; 1992.
4. Brodie, M. J. Felbamate: A new antiepileptic drug. Lancet 341: 1445-1446; 1993.
5. Chweh, A. Y.; Swinyard, E. A.; Wolf, H. H. Hypnotic action of pentobarbital in mice: A possible mechanism. Exp. Neurol. 97: 70-76; 1987.
6. Coffin, V.; Cohen-Williams, M.; Barnett, A. Selective antagonism of the anticonvulsant effects of felbamate by glycine. Eur. J. Pharmacol. 256:R9-R10; 1994.
7. De Sarro, G. B.; Ongini, E.; Bertorelli, R.; Aguglia, U.; De Sarro, A. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. Eur. J. Pharmacol. 262:11-20; 1994.
8. Domenici, M. R.; Sagratella, S.; Ongini, E.; Longo, R.; Scotti de Carolis, A. Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist. Eur. J. Pharmacol. 271:259-263; 1994.
9. Feinberg, I.; Campbell, I. G. Ketamine administration during waking increases delta EEG intensity in rat sleep. Neuropsychopharmacology 9:41-48; 1994.
10. Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N. Engl. J. Med. 27:27-34; 1993.
11. Halperin, J. M.; Miller, D.; Iorio, C. L. Sleep-inducing effects of three hypnotics in a new model of insomnia in rats. Pharmacol. Biochem. Behav.14:811-814; 1981.
12. Kälviäinen, R.; Keränen, T.; Riekkinen, P. J. Place of newer antiepileptic drugs in the treatment of epilepsy. Drugs 46:1009-1024; 1993.
13. Kemp, J. A.; Leeson, P. D. The glycine site of the NMDA receptor-Five years on. Trends Pharmacol. Sci. 14:20-25; 1993.
14. Kutt, H. Phenobarbital interactions with other drugs. In: Levy, R.; Mattson, R.; Meldrum, B.; Penry, J. K.; Dreifuss, F. E., eds. Antiepileptic drugs. 3rd ed. New York: Raven Press; 1989:313-327.
15. Lang, D. G.; Wang, C. M.; Cooper, B. R. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 266:829-835; 1993.
16. Leach, M. J.; Marden, C. M.; Miller, A. A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27: 490-497; 1986.
17. Leppik, I. E.; Dreifuss, F. E.; Pledger, G. W.; Graves, N. M.; Santilli, N.; Drury, I.; Tsay, J. Y.; Jacobs, M. P.; Bertram, E.; Cereghino, J. J.; Cooper, G.,; Sahlroot, J. T.; Sheridan, P.; Ashworth, M.; Lee, S. I.; Sierzant, T. L. Felbamate for partial seizures: Results of a controlled clinical trial. Neurology 41:1785-1789; 1991.
18. Loiseau, P.; Duche, B. Carbamazepine clinical use. In: Levy, R.; Mattson, R.; Meldrum, B.; Penry, J. K.; Dreifuss, F. E., eds. Antiepileptic drugs. 3rd ed. New York: Raven Press; 1989:533-554.
19. Macdonald, R. L.; Kelly, M. K. Antiepileptic drug mechanism of action. Epilepsia 34(Suppl. 5):S1-S8; 1993.
20. Manni, R.; Galimberti, C. A.; Zucca, C.; Parietti, L.; Tartara, A. Sleep patterns in patients with late onset partial epilepsy receiving chronic carbamazepine (CBZ) therapy. Epilepsy Res. 7:72-76; 1990.
21. Mattson, R. H. General principles. Selection of antiepileptic drug therapy. In: Levy, R.; Mattson, R.; Meldrum, B.; Penry, J. K.; Dreifuss, F. E., eds. Antiepileptic drugs. 3rd ed. New York: Raven Press; 1989:103-115.
22. Mattson, R. H.; Cramer, J. A. Phenobarbital toxicity, In: Levy, R.; Mattson, R.; Meldrum, B.; Penry, J. K.; Dreifuss, F. E., eds. Antiepileptic drugs. 3rd ed. New York: Raven Press; 1989:341-355.
23. Maudhuit, C.; Jolas, T.; Lainey, E.; Hamon, M.; Adrien, J. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology 33:1017-1025; 1994.
24. McCabe, R. T.; Wasterlain, C. G.; Kucharczyk, N.; Sofia, R. D.; Vogel, J. R. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J. Pharmacol. Exp. Ther. 264:1248-1252; 1993.
25. Mendelson, W. B. GABA-benzodiazepine receptor-chloride ionophore complex: Implications for the pharmacology of sleep. In: Wauquier, A.; Monti, J. M.; Gaillard, J. M.; Radulovacki, M., eds. Sleep. Neurotransmitters and modulators. New York: Raven Press; 1985:229-236.
26. Mendelson, W. B.; Monti, D. Do benzodiazepines induce sleep by a GABAergic mechanism? Life Sci. 53:81-87; 1993.
27. Miller, A. A.; Wheatley, P.; Sawyer, D. A.; Baxter, M. G.; Roth, B. Pharmacological studies on lamotrigine, a novel potential anti-epileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia 27:483-489; 1986.
28. Nicholson, A. N.; Belyavin, A. J.; Pascoe, P. A. Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission. Neuropsychopharmacology 2:131-143; 1989.
29. Ongini, E.; Milani, S.; Marzanatti, M.; Trampus, M.; Monopoli, A. Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 257:114-119; 1991.
30. Palmer, K. J.; McTavish, D. Felbamate: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drugs 45:1041-1065; 1993.
31. Passouant, P. Historical views on sleep and epilepsy In: Sterman, M. B.; Shouse, M. N.; Passouant, P., eds. Sleep and epilepsy. New York: Academic Press; 1982:1-6.
32. Peck, A. W. Clinical pharmacology of lamotrigine. Epilepsia 32: S9-S12; 1991.
33. Reinhard, J. F.; Reinhard, J. F., Jr. Experimental evaluation of anticonvulsants. In: Vida, J. A., ed. Anticonvulsants. New York: Academic Press; 1977:58-112.
34. Rogawski, M. A.; Porter, R. J. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42: 223-286; 1990.
35. Sachdeo, R.; Kramer, L. D.; Rosenberg, R.; Sachdeo, S. Felbamate monotherapy: Controlled trial in patient with partial onset seizures. Ann. Neurol. 32:386-392; 1992.
36. Satzinger, G. Antiepileptics from gamma-aminobutyric acid. Arzneim- Forsch/Drug Res. 44:261-266; 1994.
37. Shouse, M. N.; Siegel, J. M.; Wu, M. F.; Szymusiak, R.; Morrison, A. R. Mechanisms of seizure suppression during rapid-eye-movement (REM) sleep in cats. Brain Res. 505:271-282; 1989.
38. Swinyard, E. A.; Sofia, R. D.; Kupferberg, H. J. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia 27:27-34; 1986.
39. 1 receptor agonists A 68930 and SKF 38393 induce arousal and suppress REM sleep in the rat. Eur. J. Pharmacol. 235:83-87; 1993.
40. Van Twyver, H. Sleep patterns of five rodent species. Physiol. Behav. 4:901-905; 1969.